← Product Code [GEI](/productcode/GEI) · K972071 # BOVIE MODEL X40 (K972071) _Maxxim Medical · GEI · Oct 21, 1997 · General, Plastic Surgery · SESE_ **Canonical URL:** https://fda-staging.innolitics.com/device/K972071 ## Device Facts - **Applicant:** Maxxim Medical - **Product Code:** [GEI](/productcode/GEI.md) - **Decision Date:** Oct 21, 1997 - **Decision:** SESE - **Submission Type:** Traditional - **Regulation:** 21 CFR 878.4400 - **Device Class:** Class 2 - **Review Panel:** General, Plastic Surgery - **Attributes:** Therapeutic ## Indications for Use The BOVIE Model X40 Electrosurgical Generator is Indicated for Use in laparoscopic surgical procedures for the cutting and coagulation of human tissue. The BOVIE Model X40 can be used in conjunction with the appropriate accessories and instruments for applications in: General Surgery Gynecology Urology Gastroenterology ## Device Story BOVIE Model X40 is a high-frequency (HF) electrosurgical generator; utilizes electric current to cut and coagulate biological tissue. Device features include self-checking software for safety; real-time monitoring of neutral electrode contact; automatic detection of split/single plate electrodes; monitoring of HF leakage current and non-programmed output; audio verification of unit function and switch activation; automatic cut-off to prevent tissue overheating/electrode sticking; and automatic output adjustment based on tissue characteristics or electrode geometry. Used in clinical/surgical settings by medical professionals. Output provides thermal energy for surgical procedures; assists in maintaining precise cutting power; enhances patient safety by preventing inadvertent injury. ## Clinical Evidence Bench testing only. Safety and effectiveness demonstrated through internal testing of safety features, including automatic monitoring systems, leakage current analysis, and output control mechanisms. ## Technological Characteristics High-frequency electrosurgical generator; utilizes electric current for thermal tissue effects. Features include real-time neutral electrode monitoring, HF leakage current monitoring, and automatic output adjustment. Includes self-checking software for safety diagnostics. Operates via foot or finger switch activation with audio verification. ## Regulatory Identification An electrosurgical cutting and coagulation device and accessories is a device intended to remove tissue and control bleeding by use of high-frequency electrical current. ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0}------------------------------------------------ Notification Model X40 Electrosurgical Generator May 30, 1997 OCT 2 | 1997 ## SUMMARY STATEMENT OF SAFETY AND EFFECTIVENESS K972071 For more than 50 years, high-frequency (HF) surgery has been used to cut and/or coagulate biological tissue using the intrinsic thermal effect of electric current. Berchtold has produced a state-of-the-art electrosurgical generator for international distribution. The BOVIE Model X40 represents one of the latest of these instruments. It is based upon Berchtold's long standing commitment to the provision of high quality surgical equipment and is produced in accordance with established international standards for such instruments. In order to protect the patient and user from inadvertent injury from the use of this instrument it is provided with several safety features. These include: Self checking software which performs an automatic safety check each time the instrument is turned on. Real time, continuous monitoring of the patient contact with the neutral electrode. Automatic detection of the use of split or single plate neutral electrode. Automatic monitoring of HF leakage current and non-programed output. Automatic detection and display of malfunction. State-of-the-art control panel with audio (spoken) verification of unit function and confinmation of foot or finger switch activation. Automatic cut-off to prevent excess tissue over-heating and electrode sticking. Automatically adjusted output to ensure the cutting power is maintained at the minimum level required to effect the cut as tissue characteristics or electrode geometry change. We believe the above mentioned safety features, and the test results obtained and included in this 510(k) Notification demonstrate that the BOVIE Model X40 is safe and effective for its intended use. {1}------------------------------------------------ Image /page/1/Picture/1 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo is circular and contains the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. In the center of the circle is an abstract symbol that resembles an eagle or bird in flight. The logo is black and white. Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20856 OCT 2 1 1997 Mr. Michael A. Clark South East Regulatory Associates, Inc. 1070 Thornwood Lane Dacula, Georgia 30211-3007 Re: K972071 Trade Name: BOVIE Model X40 Regulatory Class: II Product Code: GEI Dated: September 8, 1997 Received: September 10, 1997 Dear Mr. Clark: We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the current Good Manufacturing Practice requirements , as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic (QS) inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations. {2}------------------------------------------------ Page 2 - Mr. Michael A. Clark This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4595. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsmamain.html". Sincerely yours, Sincerely yours, Celia M. Witten, Ph.D., M.D. Director Division of General and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {3}------------------------------------------------ K972071 May 30, 1997 510(k) Notification BOVIE Model X40 Electrosurgical Generator INDICATIONS FOR USE The BOVIE Model X40 Electrosurgical Generator is Indicated for Use in laparoscopic surgical procedures for the cutting and coagulation of human tissue. The BOVIE Model X40 can be used in conjunction with the appropriate accessories and instruments for applications in: General Surgery Gynecology Urology Gastroenterology Concurrence of CDRH, Office of Device Evaluation (ODE) | (Division Sign-Off) | | |-----------------------------------------|---------| | Division of General Restorative Devices | | | 510(k) Number | K972071 | | Prescription Use
(Per 21 CFR 801.109) | OR | Over-The-Counter Use | |------------------------------------------|----|----------------------| |------------------------------------------|----|----------------------| --- **Source:** [https://fda-staging.innolitics.com/device/K972071](https://fda-staging.innolitics.com/device/K972071) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com